BBC vs. PFFR
BBC (Virtus LifeSci Biotech Clinical Trials ETF) and PFFR (InfraCap REIT Preferred ETF) are both exchange-traded funds - BBC is a Health & Biotech Equities fund tracking the LifeSci Biotechnology Clinical Trials Index, while PFFR is a Preferred Stock/Convertible Bonds fund tracking the Indxx REIT Preferred Stock Index. Both are passively managed. Over the past 5 years, BBC returned -2.05%/yr vs 1.03%/yr for PFFR. At a 0.27 correlation, their price movements are largely independent. BBC charges 0.79%/yr vs 0.45%/yr for PFFR.
Performance
BBC vs. PFFR - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BBC achieves a 8.17% return, which is significantly higher than PFFR's 1.03% return.
BBC
- 1D
- -4.90%
- 1M
- -4.81%
- YTD
- 8.17%
- 6M
- 20.12%
- 1Y
- 123.11%
- 3Y*
- 19.82%
- 5Y*
- -2.05%
- 10Y*
- 7.60%
PFFR
- 1D
- 0.05%
- 1M
- -0.69%
- YTD
- 1.03%
- 6M
- 1.36%
- 1Y
- 7.97%
- 3Y*
- 9.35%
- 5Y*
- 1.03%
- 10Y*
- —
BBC vs. PFFR - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BBC Virtus LifeSci Biotech Clinical Trials ETF | 8.17% | 63.77% | -1.11% | -1.80% | -35.13% | -22.31% | 30.32% | 63.81% | -18.29% | 42.94% |
PFFR InfraCap REIT Preferred ETF | 1.03% | 5.36% | 7.12% | 21.04% | -23.90% | 6.76% | 0.19% | 20.28% | -7.45% | 7.60% |
Correlation
The correlation between BBC and PFFR is 0.21, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.21 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.23 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.29 |
Correlation (All Time) Calculated using the full available price history since Feb 9, 2017 | 0.27 |
BBC vs. PFFR - Sectors Allocation Comparison
Sectors
BBC
PFFR
Healthcare
-
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
Industrials
-
-
Real Estate
-
Technology
-
-
Utilities
-
-
Healthcare
BBC
PFFR
-
Basic Materials
BBC
-
PFFR
-
Communication Services
BBC
-
PFFR
-
Consumer Cyclical
BBC
-
PFFR
-
Consumer Defensive
BBC
-
PFFR
-
Energy
BBC
-
PFFR
-
Financial Services
BBC
-
PFFR
Industrials
BBC
-
PFFR
-
Real Estate
BBC
-
PFFR
Technology
BBC
-
PFFR
-
Utilities
BBC
-
PFFR
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BBC vs. PFFR — Risk / Return Rank
BBC
PFFR
BBC vs. PFFR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Virtus LifeSci Biotech Clinical Trials ETF (BBC) and InfraCap REIT Preferred ETF (PFFR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BBC | PFFR | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 3.49 | 1.01 | +2.48 |
Sortino ratioReturn per unit of downside risk | 4.11 | 1.47 | +2.64 |
Omega ratioGain probability vs. loss probability | 1.48 | 1.18 | +0.30 |
Calmar ratioReturn relative to maximum drawdown | 8.82 | 1.02 | +7.80 |
Martin ratioReturn relative to average drawdown | 28.55 | 2.39 | +26.16 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| BBC | PFFR | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 3.49 | 1.01 | +2.48 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.05 | 0.10 | -0.15 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.20 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.12 | 0.16 | -0.04 |
Drawdowns
BBC vs. PFFR - Drawdown Comparison
The maximum BBC drawdown since its inception was -76.85%, which is greater than PFFR's maximum drawdown of -53.02%. Use the drawdown chart below to compare losses from any high point for BBC and PFFR.
Loading charts...
Drawdown Indicators
| BBC | PFFR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -76.85% | -53.02% | -23.83% |
Max Drawdown (1Y)Largest decline over 1 year | -15.10% | -6.57% | -8.53% |
Max Drawdown (3Y)Largest decline over 3 years | -54.45% | -11.16% | -43.29% |
Max Drawdown (5Y)Largest decline over 5 years | -72.44% | -29.80% | -42.64% |
Max Drawdown (10Y)Largest decline over 10 years | -76.85% | — | — |
Current DrawdownCurrent decline from peak | -30.57% | -2.84% | -27.73% |
Average DrawdownAverage peak-to-trough decline | -37.14% | -7.00% | -30.14% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.66% | 2.79% | +1.87% |
Volatility
BBC vs. PFFR - Volatility Comparison
Virtus LifeSci Biotech Clinical Trials ETF (BBC) has a higher volatility of 11.21% compared to InfraCap REIT Preferred ETF (PFFR) at 2.81%. This indicates that BBC's price experiences larger fluctuations and is considered to be riskier than PFFR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BBC | PFFR | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.21% | 2.81% | +8.40% |
Volatility (6M)Calculated over the trailing 6-month period | 26.65% | 6.13% | +20.52% |
Volatility (1Y)Calculated over the trailing 1-year period | 35.74% | 8.00% | +27.74% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 39.31% | 10.47% | +28.84% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 37.75% | 20.54% | +17.21% |
BBC vs. PFFR - Expense Ratio Comparison
BBC has a 0.79% expense ratio, which is higher than PFFR's 0.45% expense ratio.
Dividends
BBC vs. PFFR - Dividend Comparison
BBC's dividend yield for the trailing twelve months is around 1.57%, less than PFFR's 8.27% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BBC Virtus LifeSci Biotech Clinical Trials ETF | 1.57% | 1.70% | 1.00% | 0.34% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 2.09% | 0.00% | 0.51% |
PFFR InfraCap REIT Preferred ETF | 8.27% | 7.99% | 7.78% | 7.72% | 8.60% | 6.08% | 6.11% | 5.77% | 6.48% | 6.59% | 0.00% | 0.00% |
Frequently Asked Questions
BBC and PFFR have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BBC has higher volatility (11.21%) compared to PFFR (2.81%). In terms of maximum drawdown, BBC dropped -76.85% vs PFFR's -53.02%.
On 5-year performance, PFFR leads with 1.03% vs -2.05% for BBC. On fees, PFFR is cheaper at 0.45% per year. On volatility, PFFR has been the lower-risk option at 2.81%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, PFFR has performed better with a 1.03% return vs -2.05%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
PFFR is cheaper with a 0.45% expense ratio, compared with 0.79% for BBC.
PFFR has the higher dividend yield at 8.27%, compared with 1.57% for BBC.
BBC is categorized as Health & Biotech Equities, while PFFR is Preferred Stock/Convertible Bonds. BBC tracks LifeSci Biotechnology Clinical Trials Index, while PFFR tracks Indxx REIT Preferred Stock Index. Their fees differ too: 0.79% for BBC and 0.45% for PFFR.
BBC currently has the higher Sharpe Ratio (3.49 vs 1.01), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BBC and PFFR
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer